The marked reduction in time spent with glucose >250 mg/dL in the subgroup with baseline HbA1c values ≥10% was achieved without significant differences in diabetes medication changes between groups, including the initiation of prandial insulin. This evidence concerns the gene INS and diabetes mellitus.